In vitro method for the diagnosis and monitoring of cancer, which includes determining the ratio of Treg cells and another group of selected T cells, Th17 and Th1 / Th2, or.

摘要

The present invention relates to an in vitro method for the diagnosis and/or the monitoring and/or predicting the progress of a cancer disease, characterized in that in at least one sample the ratio of Tregs-cells to at least one other group of T cells comprising the group of Th17 cells, Th1 cells and/or Th2 cells is determined.